Published in Am J Bioeth on January 01, 2009
Managing Ethical Challenges to Mental Health Research in Post-Conflict Settings. Dev World Bioeth (2015) 0.79
Physician-Researchers' Experiences of the Consent Process in the Sociocultural Context of a Developing Country. AJOB Prim Res (2011) 0.78
The Is-Ought Problem in Practical Ethics. HEC Forum (2017) 0.75
The role of empirical research in bioethics. Am J Bioeth (2009) 12.06
Grand challenges in global mental health. Nature (2011) 8.40
Grand challenges in global health: community engagement in research in developing countries. PLoS Med (2007) 4.75
Global health ethics for students. Dev World Bioeth (2009) 2.93
Brazilian health biotech--fostering crosstalk between public and private sectors. Nat Biotechnol (2008) 2.57
India's health biotech sector at a crossroads. Nat Biotechnol (2007) 2.53
DNA databanks and consent: a suggested policy option involving an authorization model. BMC Med Ethics (2003) 2.42
Ethics and SARS: lessons from Toronto. BMJ (2003) 2.39
Grand challenges in global health: the ethical, social and cultural program. PLoS Med (2007) 2.02
The effect of universal influenza immunization on mortality and health care use. PLoS Med (2008) 2.01
Chinese health biotech and the billion-patient market. Nat Biotechnol (2008) 2.00
The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis (2009) 1.77
A tough transition. Nature (2007) 1.75
Pandemic influenza preparedness: an ethical framework to guide decision-making. BMC Med Ethics (2006) 1.75
Global health. Stagnant health technologies in Africa. Science (2010) 1.68
Grand challenges in global health: engaging civil society organizations in biomedical research in developing countries. PLoS Med (2007) 1.68
Nanotechnology and the developing world. PLoS Med (2005) 1.66
Evidence-based medicine in primary care: qualitative study of family physicians. BMC Fam Pract (2003) 1.65
Small but tenacious: South Africa's health biotech sector. Nat Biotechnol (2009) 1.63
Determining use of preventive health care in Ontario: comparison of rates of 3 maneuvers in administrative and survey data. Can Fam Physician (2009) 1.56
Race and ancestry in biomedical research: exploring the challenges. Genome Med (2009) 1.55
Psychosocial effects of SARS on hospital staff: survey of a large tertiary care institution. CMAJ (2004) 1.51
How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician (2011) 1.51
Grand challenges in global health: ethical, social, and cultural issues based on key informant perspectives. PLoS Med (2007) 1.50
Croup hospitalizations in Ontario: a 14-year time-series analysis. Pediatrics (2005) 1.49
Needed: models of biotechnology intellectual property. Trends Biotechnol (2002) 1.48
Global health challenges: the need for an expanded discourse on bioethics. PLoS Med (2005) 1.46
The three main monotheistic religions and gm food technology: an overview of perspectives. BMC Int Health Hum Rights (2009) 1.45
Innovative health service delivery models in low and middle income countries - what can we learn from the private sector? Health Res Policy Syst (2010) 1.44
Grand challenges: Integrating mental health care into the non-communicable disease agenda. PLoS Med (2013) 1.42
MedsCheck: an opportunity missed. CMAJ (2008) 1.40
Chaperone use during intimate examinations in primary care: postal survey of family physicians. BMC Fam Pract (2005) 1.39
Conclusions: promoting biotechnology innovation in developing countries. Nat Biotechnol (2004) 1.38
South Africa--blazing a trail for African biotechnology. Nat Biotechnol (2004) 1.34
SARS and hospital priority setting: a qualitative case study and evaluation. BMC Health Serv Res (2004) 1.33
Influenza and pneumonia hospitalizations in Ontario: a time-series analysis. Epidemiol Infect (2004) 1.30
Whole genome scanning: resolving clinical diagnosis and management amidst complex data. Pediatr Res (2009) 1.29
Science community: scientific diasporas. Science (2006) 1.29
The IMPACT clinic: innovative model of interprofessional primary care for elderly patients with complex health care needs. Can Fam Physician (2013) 1.28
State of academic knowledge on toxicity and biological fate of quantum dots. Toxicol Sci (2009) 1.23
The global alliance for chronic diseases. Science (2009) 1.23
Harnessing stem cells for health needs in India. Cell Stem Cell (2008) 1.19
Biotechnology and the UN's Millennium Development Goals. Nat Biotechnol (2003) 1.19
From clinical observation to clinical discovery: the challenge for family medicine research. Can Fam Physician (2014) 1.19
'Relief of oppression': an organizing principle for researchers' obligations to participants in observational studies in the developing world. BMC Public Health (2010) 1.19
Family physicians' attitudes toward education in research skills during residency: findings from a national mailed survey. Can Fam Physician (2008) 1.16
Trends in health services utilization, medication use, and health conditions among older adults: a 2-year retrospective chart review in a primary care practice. BMC Health Serv Res (2009) 1.15
Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives. BMC Med Ethics (2004) 1.14
A prospective study of physician-observed concussions during junior ice hockey: implications for incidence rates. Neurosurg Focus (2010) 1.14
Regenerative medicine in Brazil: small but innovative. Regen Med (2010) 1.12
Genomics--a global public good? Lancet (2003) 1.11
Shared principles of ethics for infant and young child nutrition in the developing world. BMC Public Health (2010) 1.11
Reporting of informed consent, standard of care and post-trial obligations in global randomized intervention trials: a systematic survey of registered trials. Dev World Bioeth (2008) 1.10
Introduction: promoting global health through biotechnology. Nat Biotechnol (2004) 1.10
Introducing new technologies: protecting subjects of surgical innovation and research. World J Surg (2003) 1.09
Cuba--innovation through synergy. Nat Biotechnol (2004) 1.06
"Harnessing genomics to improve health in India" - an executive course to support genomics policy. Health Res Policy Syst (2004) 1.06
Priority setting for orphan drugs: an international comparison. Health Policy (2010) 1.04
The seasonality of total hospitalizations in Ontario by age and gender: a time series analysis. Can J Public Health (2003) 1.04
Genomics knowledge and equity: a global public goods perspective of the patent system. Bull World Health Organ (2004) 1.03
Lessons on ethical decision making from the bioscience industry. PLoS Med (2006) 1.03
Patients' perspectives on taking warfarin: qualitative study in family practice. BMC Fam Pract (2004) 1.03
Seasonality of primary care utilization for respiratory diseases in Ontario: a time-series analysis. BMC Health Serv Res (2008) 1.02
The CNCDs and the NTDs: blurring the lines dividing noncommunicable and communicable chronic diseases. PLoS Negl Trop Dis (2008) 1.02
A population-based cohort study of ambulatory care service utilization among older adults. J Eval Clin Pract (2010) 1.01
Public engagement on global health challenges. BMC Public Health (2008) 1.01
Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN). Nat Rev Genet (2008) 1.01
Genomic medicine and developing countries: creating a room of their own. Nat Rev Genet (2008) 0.99
Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant (2011) 0.99
Return to play after an initial or recurrent concussion in a prospective study of physician-observed junior ice hockey concussions: implications for return to play after a concussion. Neurosurg Focus (2010) 0.99
South-South entrepreneurial collaboration in health biotech. Nat Biotechnol (2010) 0.99
Indian biotechnology--rapidly evolving and industry led. Nat Biotechnol (2004) 0.98
Warfarin therapy and risk of hip fracture among elderly patients. Pharmacotherapy (2003) 0.98
Long term benzodiazepine use for insomnia in patients over the age of 60: discordance of patient and physician perceptions. BMC Fam Pract (2002) 0.97
A survey of South-North health biotech collaboration. Nat Biotechnol (2009) 0.96
A qualitative study of the duty to care in communicable disease outbreaks. Soc Sci Med (2007) 0.96
South Africa: from species cradle to genomic applications. Nat Rev Genet (2008) 0.96
The assessment and treatment of a complex geriatric patient by an interprofessional primary care team. BMJ Case Rep (2011) 0.96
Mortality of elderly patients in Ontario after hospital admission for chronic obstructive pulmonary disease. Can Respir J (2007) 0.96
The next steps for genomic medicine: challenges and opportunities for the developing world. Nat Rev Genet (2008) 0.96
Theatre as a public engagement tool for health-policy development. Health Policy (2005) 0.96
Science-based health innovation in sub-Saharan Africa. BMC Int Health Hum Rights (2010) 0.95
Feasibility of a patient decision aid regarding disclosure of personal health information: qualitative evaluation of the Health Care Information Directive. BMC Med Inform Decis Mak (2004) 0.94
Anesthesia, ethics, and severe acute respiratory syndrome. Can J Anaesth (2003) 0.94
Therapeutic benefit of preventive telehealth counseling in the Community Outreach Heart Health and Risk Reduction Trial. Am J Cardiol (2011) 0.93
The nexus of evidence, context, and patient preferences in primary care: postal survey of Canadian family physicians. BMC Fam Pract (2003) 0.93
Oral vitamin B12 therapy in the primary care setting: a qualitative and quantitative study of patient perspectives. BMC Fam Pract (2005) 0.93
Hepatitis B virus infected physicians and disclosure of transmission risks to patients: a critical analysis. BMC Med Ethics (2001) 0.92
"Harnessing genomics to improve health in Africa" - an executive course to support genomics policy. Health Res Policy Syst (2005) 0.92
The scientific muscle of Brazil's health biotechnology. Nat Biotechnol (2004) 0.91
Health biotechnology in China--reawakening of a giant. Nat Biotechnol (2004) 0.91
Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators. Health Res Policy Syst (2012) 0.91
Strengthening the role of genomics in global health. PLoS Med (2004) 0.91
Contextual factors in clinical decision making: national survey of Canadian family physicians. Can Fam Physician (2005) 0.90
South Korean biotechnology--a rising industrial and scientific powerhouse. Nat Biotechnol (2004) 0.90
Cultivating regenerative medicine innovation in China. Regen Med (2010) 0.90